产品编号：CLATOX100
市 场 价：¥15500.00
场 地：美国(厂家直采)
联系QQ：1570468124
电话号码：4000-520-616
邮 箱：
info@ebiomall.com
商品介绍
- Description
- Additional Information
- Readable Documents
- Assay Principle
- Reviews
Key Benefits
- Safe – Non Radioactive Enzyme release assay.
- Versatile – Useful for measuring activity of T Cells, Primary Cells, NK, complement and other lytic agents.
- Assay can be run in serum supplemented media.
- Homogenous – One-step, no wash assay. Assay can be run in same plate as samples.
- FAST – Results in 3-5 minutes. Chromium 51 or europium release for measurement are time consuming. The inherent sensitivity of luciferase detection is enhanced by the amplification effect of enzyme turnover, which produces thousands, millions or billions of high – energy molecules for each molecule of the enzyme.
- Highly Sensitive – Can detect fewer than 500 cells/well in the presence of serum or as few as 10 cells/well in serum-free or heat-killed media.
- GAPDH: The fact that GAPDH is a natural component of cells, and does not need to be introduced into the cells in any manner, distinguishes this assay from all methods which require prelabelling of cells, transfection, transformation, or other methods of introducing proteins or other molecules into the target cells in order to generate a signal in a later step.
- Advantages for measurement of cell mediated or complement mediated cytolysis – It is usually desirable to use smaller numbers of TCells than are needed for the 51Cr – release assay, since excessive numbers of effector cells can increase the background signal. This is now possible due to the high sensitivity of aCella-Tox.
- ADCC / CMC Assays – A non radioactive alternative to 51Cr assays. Please click here for a direct comparison between the aCella-TOX and (51Cr) Chromium Release Methods
- HTS – Adaptable for High Throughput format
- Non-destructive assay allows monitoring of additional parameters.
Additional information
| Kit Size | 500, 1000 |
|---|---|
| Includes | No Plates, 5 Lumi Plates, 5 Lumi Plates + 5 Tissue Culture Plates |
GAPDH is an important enzyme in the glycolysis and gluconeogenesis pathways. This homotetrameric enzyme catalyzes the oxidative phosphorylation of D-glyceraldehyde-3-phosphate to 1,3-diphosphoglycerate in the presence of cofactor and inorganic phosphate. In the aCella-TOX reaction scheme the release of GAPDH is coupled to the activity of the enzyme 3-Phosphoglyceric Phosphokinase (PGK) to produce ATP. ATP is detected via the luciferase, luciferin Bioluminescence methodology. Further, aCella-TOX is a homogeneous cytotoxicity assay; alternatively in dual mode, aCella-TOX can measure cytotoxicity and cell viability in the same plate. Culture supernatants can also be removed from the original plate and assayed in a different plate, allowing kinetics runs to be set up. The assay is non-destructive, allowing the monitoring of additional parameters such as gene expression.
| Document Title |
| aCella-TOX v1_3 Protocol |
| aCella-TOX Datasheet |
| msds.aCella-TOX |
| Title | File | Link | Author(s) | Journal | Year; Edition:Pages |
| Heat shock enhances the expression of cytotoxic granule proteins and augments the activities of tumor-associated antigen-specific cytotoxic T lymphocytes. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468674/ | Takahashi A, Torigoe T, Tamura Y, et al. | Cell Stress & Chaperones | 2012;17(6):757-763 | |
| IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptides. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368154/ | Foy KC, Miller MJ, Overholser J, Donnelly SM, Nahta R, Kaumaya PT | Oncoimmunology | 2014;3(11):e956005 | |
| HER-3 peptide vaccines/mimics: Combined therapy with IGF-1R, HER-2, and HER-1 peptides induces synergistic antitumor effects against breast and pancreatic cancer cells. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368151/ | Miller MJ, Foy KC, Overholser JP, Nahta R, Kaumaya PT | Oncoimmunology | 2014;3(11):e956012 | |
| Phase I Active Immunotherapy With Combination of Two Chimeric, Human Epidermal Growth Factor Receptor 2, B-Cell Epitopes Fused to a Promiscuous T-Cell Epitope in Patients With Metastatic and/or Recurrent Solid Tumors. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773479/ | Kaumaya PTP, Foy KC, Garrett J, et al. | Journal of Clinical Oncology | 2009;27(31):5270-5277 | |
| Identification of Cellular Proteins Required for Replication of Human Immunodeficiency Virus Type 1. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448097/ | Dziuba N, Ferguson MR, O"Brien WA, et al. | AIDS Research and Human Retroviruses | 2012;28(10):1329-1339 | |
| Insulin-Like Growth Factor-1 Receptor Signaling Increases the Invasive Potential of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Cells via Src-Focal Adhesion Kinase and Forkhead Box Protein M1. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293451/ | Sanabria-Figueroa E, Donnelly SM, Foy KC, et al. | Pharmacology | 2015;87(2):150-161 | |
| Combination Treatment with HER-2 and VEGF Peptide Mimics Induces Potent Anti-tumor and Anti-angiogenic Responses in Vitro and in Vivo. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075707/ | Foy KC, Liu Z, Phillips G, Miller M, Kaumaya PTP | The Journal of Biological Chemistry | 2011;286(15):13626-13637 | |
| Resistance to Cytarabine Induces the Up-regulation of NKG2D Ligands and Enhances Natural Killer Cell Lysis of Leukemic Cells. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586691/ | Ogbomo H, Michaelis M, Klassert D, Doerr HW, Cinatl J. | Neoplasia (New York, NY) | 2008;10(12):1402-1410 | |
| Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC). | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586465/ | Overholser J, Ambegaokar KH, Eze SM, et al. | Disis ML (Nora), ed. Vaccines | 2015;3(3):519-543 | |
| Generation and preclinical characterization of an antibody specific for SEMA4D. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966508/ | Fisher TL, Reilly CA, Winter LA, et al. | mAbs | 2016;8(1):150-162 | |
| A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411161/ | Simhadri VR, Dimitrova M, Mariano JL, et al. | Reeves RK, ed. PLoS ONE | 2015;10(4):e0124677 | |
| Natural Cytotoxicity Receptor-Dependent Natural Killer Cytolytic activity Directed at Hepatitis C Virus (HCV) Is Associated With Liver Inflammation, African American Race, IL28B Genotype, and Response to Pegylated Interferon/Ribavirin Therapy in Chronic HCV Infection. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997579/ | Meng Q, Rani MRS, Sugalski JM, et al. | The Journal of Infectious Diseases | 2014;209(10):1591-1601 | |
| Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas In Vitro and In Vivo. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677932/ | Ogbomo H, Zemp FJ, Lun X, et al. | Ulasov I, ed. PLoS ONE | 2013;8(6):e66825 | |
| Targeting a Glioblastoma Cancer Stem Cell Population Defined by EGF Receptor Variant III. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661963/ | Emlet DR, Gupta P, Holgado-Madruga M, et al. | Cancer research | 2014;74(4):1238-1249 | |
| Genetically Associated CD16+56− Natural Killer Cell Interferon (IFN)-αR Expression Regulates Signaling and Is Implicated in IFN-α-Induced Hepatitis C Virus Decline. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295604/ | Conry SJ, Meng Q, Hardy G, et al. | The Journal of Infectious Diseases | 2012;205(7):1131-1141 |
| Reference |
| Methods and compositions for coupled luminescent assays. United States Patent 6,811,990 Corey and Kinders, issued November 2, 2004. |
| Corey, M. J. and Kinders, R. J. (2005) "Coupled Luminescent Methods in Drug Discovery: 3-Min Assays for Cytotoxicity and Phosphatase Activity" Drug Discovery Handbook, Ed. Shayne Cox Gad, published by John Wiley & Sons, Inc., pp. 689-731 |
| Corey, M.J., et al., "A Very Sensitive Coupled Luminescent Assay for Cytoxicity and Complement-Mediated Lysis," Journal of Immunological Methods 207:43-51, 1997. |
| Corey, M. J., et al., Mechanistic Studies of the Effects of Anti-factor H Antibodies on Complement-mediated Lysis,” Journal of Biological Chemistry 275: 12917-12925, 2000. |
| Schafer, H., et al., "A Highly Sensitive Cytotoxicity Assay Based on the Release of Reporter Enzymes, From Stably Transfected Cell Lines," Journal of Immunological Methods 204:89-98, 1997. |
| Racher, LDH Assay, in Cell and tissue culture: Laboratory procedures in biotechnology, A. Doyle and J.B. Griffiths, Eds. 1998, John Wiley & Sons: Chichester, New York, Weinheim. p. 71-5 |
| Decker, T. and Lohmann-Matthes, M.L. (1988) A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Meth. 115, 61-9. |
| Korzeniewski, C. and Callewaert, D.M. (1983) An enzyme-release assay for natural cytotoxicity. J. Immunol. Meth.64, 313-20. |
| Crouch, S.P.M., et al., "The Use of ATP Bioluminescence as a Measure of Cell Proliferation and Cytotoxicity," Journal of Immunological Methods 160:81-88, 1993. |
| Henry Ogbomo, Anke Hahn, Janina Geiler, Martin Michaelis, Hans Wilhelm Doerr, Jindrich Cinatl Jr. NK sensitivity of Neuroblastoma cells determined by a highly sensitive coupled luminescent method;Biochemical and Biophysical Research Comunications 339 (2006) pp375-379. Click here to read the publication |
| Part# | Reagent | Temperature |
| Part # 6001 | 4X Enzyme Assay Reagent | -20C |
| Part # 3008 | 1X Enzyme Assay Diluent | 2-8C |
| Part # 6003 | Glyeraldehyde 3-Phosphate (G3P) | -20C |
| Part # 6002 | 50X Detection Reagent | -20C |
| Part # 3009 | 5.5X Detection Assay Diluent | -20C |
| Part # 3035 | Lytic Agent | 2-8C |
| N/A | 5 Lumi Plates (Catalog# CLATOX100-3L) | N/A |
| N/A | 5 Lumi Plates + 5 Tissue Culture Plates (Catalog# CLATOX100-3P) | N/A |
品牌介绍
Cell Signaling Technology (CST) 是一家由科学家创立的私营家族公司，致力于提供全球最高品质的创新研究和诊断产品，加速生物学认知以及实现个体化医疗。CST坚持自主生产和严格验证，其高质量的产品和专业的研发精神已被全球客户认可，被公认/票选为细胞信号研究的金标准、最佳抗体*、研究者的选择*、PTM（蛋白翻译后修饰）年度抗体公司*、十年抗体品牌*等（*来自CiteAb、LISA数据报告）。
CST提供最高品质的特色信号蛋白及磷酸化、甲基化、乙酰化、泛素化、SUMO化等翻译后修饰抗体，蛋白翻译后修饰筛选试剂盒及服务，还有偶联抗体，二抗，ChIP试剂盒，细胞因子，ELISA试剂盒，细胞检测试剂盒，蛋白实验配套试剂等，为您提供蛋白相关实验的一站式解决方案。
厂家直采
全球直采 正品优价
正品保障
厂家直发 有线跟踪
正规清关
CIF100%正规报关，提供发票
及时交付
限时必达 不达必赔
总部地址：
江苏省苏州市工业园区星湖街218号 苏州生物医药产业园一期（生物纳米园）A4-216(邮编：215125)
工作时间：周一至周五9:00~18:00
技术支持：
短信：18915418616
服务热线：
4000-520-616（全国）
☏ 0512-67156496（苏州）
版权信息：
© 2015- 苏州蚂蚁淘生物科技有限公司 版权所有 中国
友情链接：
免责声明：
本站有部分内容来自互联网，如无意中侵犯了某个媒体 、公司 、企业或个人等的知识产权，请来电或致函告之，
本网站将在规定时间内给予删除等相关处理。
本网站将在规定时间内给予删除等相关处理。
扫描二维码关注官方微信
获取最新促销及产品信息